Thyrocare Technologies Announcements
Please find attached herewith Intimation of receipt of Awards.
22 Jan, 2026 | 09:33pm • Source: BSE
We wish to intimate that a conference call for the analysts/ investors is arranged by our management to discuss the Company''s Unaudited Financial Results for...
20 Jan, 2026 | 04:16pm • Source: BSE
Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and...
20 Jan, 2026 | 03:21pm • Source: BSE
Please find attached herewith intimation regarding change of name of M S K A & Associates, Chartered Accountants to M S K A & Associates...
17 Jan, 2026 | 09:36pm • Source: BSE
Please find attached herewith Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025
08 Jan, 2026 | 06:04pm • Source: BSE
Thyrocare Technologies Limited has informed the Exchange regarding Appointment of Mr. Rajdeep Panwar as Chief Commercial Officer of the company w.e.f. January 05, 2026
05 Jan, 2026 | 01:36pm • Source: NSE
Appointment of Mr. Rajdeep Panwar as Chief Commercial Officer of the Company.
05 Jan, 2026 | 11:12am • Source: BSE
Thyrocare Technologies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
23 Dec, 2025 | 12:03pm • Source: NSE
Please find attached herewith the Intimation for Closure of Trading Window
23 Dec, 2025 | 11:50am • Source: BSE
Thyrocare Technologies Limited has informed the Exchange regarding Appointment of Dr. Ramesh Kinha as Chief Operating Officer of the Company w.e.f. December 18, 2025
18 Dec, 2025 | 11:25am • Source: NSE
Thyrocare Technologies Limited has informed the Exchange about the Appointment of Dr. Ramesh Kinha as Chief Operating Officer (COO) of the Company
18 Dec, 2025 | 11:24am • Source: NSE
Appointment of Dr. Ramesh Kinha as Chief Operating Officer (COO) of the Company
18 Dec, 2025 | 10:42am • Source: BSE
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST)...
05 Dec, 2025 | 06:01pm • Source: BSE
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 05, 2025 for...
05 Dec, 2025 | 06:00pm • Source: BSE
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
04 Dec, 2025 | 10:26am • Source: BSE
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd
03 Dec, 2025 | 10:14am • Source: BSE
Thyrocare Technologies Limited has informed the Exchange regarding allotment of 10,61,07,794 securities pursuant to Bonus at its meeting held on December 01, 2025
01 Dec, 2025 | 10:00am • Source: NSE
Allotment of Bonus Equity Shares.
01 Dec, 2025 | 08:53am • Source: BSE
Intimation regarding the Change in Senior Management Personnel of the Company
29 Nov, 2025 | 11:55am • Source: BSE
This is to inform you that an advertisement on Record Date for issue of Bonus Equity Shares has been published today i.e., November 17, 2025...
17 Nov, 2025 | 03:18pm • Source: BSE